At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
Active transcutaneous spinal direct current stimulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Spinal Cord Stimulation for the Treatment of Major Depressive Disorder
In Brief
A Phase 2 clinical trial evaluating Active transcutaneous spinal direct current stimulation and Sham transcutaneous spinal direct current stimulation for Major Depressive Disorder. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This pilot clinical trial will evaluate the efficacy and safety of transcutaneous direct current stimulation (tsDCS) in major depressive disorder.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesUnited States
CollaboratorsLindner Center of HOPE, Brain & Behavior Research Foundation
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartAug 2018
Primary CompletionSep 2022
TodayJul 2026
First PostedFeb 14, 2018
Enrollment StartAug 29, 2018
Primary CompletionSep 13, 2022
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 8.4 years ago
Interventions
Active transcutaneous spinal direct current stimulationdevice
Active anode electrodes placed at Thoracic 10 level, Cathode electrode placed on right shoulder.
Sham transcutaneous spinal direct current stimulationdevice
Sham anode electrodes placed at Thoracic 10 level, Cathode electrode placed on right shoulder.